Public Policy Resources

The Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program (CRCCP) provides grant funding to 20 state health departments, eight universities, two tribal organizations, and five other organizations to help prevent colorectal cancer, the third most common cancer in men and women and the second leading cause of cancer death in the U.S. for men and women combined.

Our latest survey finds that cancer patients and survivors would be less likely to stay current with preventive care, including recommended cancer screenings, if the provision requiring these services be covered at no cost were repealed. This survey also explores the challenges of limited provider networks and the need for patient navigation.

Prostate cancer is the most common cancer in Black men. Black men are over twice as likely to die from prostate cancer compared to every other racial and ethnic group and they are also more likely to be diagnosed at an advanced stage. Black men with lower-grade (less aggressive) disease are actually more likely to die from prostate cancer than white men. The reasons for this are complex and include interactions between social, behavioral and biological factors.

Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. Yet, about 1 in 3 adults aged 50 to 75 are not getting tested as recommended. This factsheet discusses the importance of screening for colorectal cancer and what can be done to improve screening in the U.S.

In the U.S., colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. Despite advancements in screening and treatment, CRC does not affect every community the same. 

If detected early, cervical cancer is one of the most successfully treatable cancers. Incidence and mortality rates of cervical cancer have declined by over 50 percent in the past 40 years, largely due to improved screening and early detection. However, the rate of decline has slowed in recent years. Efforts to reduce barriers to screening could greatly improve cervical cancer screening rates, particularly for disparate populations.